Clinical trial
Double-Blind, Randomized, Placebo-Controlled Trial of AKST4290 for Adjunctive Treatment of Mild to Moderate Bullous Pemphigoid
NCT04499235 is registered in ClinicalTrials.gov with Alkahest, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Randomized, Placebo-Controlled Trial of AKST4290 for Adjunctive Treatment of Mild to Moderate Bullous Pemphigoid
- Lead sponsor
- Alkahest, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 30, 2020
- Completion date
- April 14, 2021
- Enrollment
- 6 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.